Nanostructured lipid carriers system: recent advances in drug delivery.
about
Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposureRecent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesCapsaicin-loaded nanolipoidal carriers for topical application: design, characterization, and in vitro/in vivo evaluation.Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach.Nanoparticles and nanofibers for topical drug delivery.An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cellsNanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophagesNanostructured lipid carriers: versatile oral delivery vehicle.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosisTopical delivery of ocular therapeutics: carrier systems and physical methods.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Lipid nanoparticles for the topical delivery of retinoids and derivatives.New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assemblies.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Topical drug delivery systems: a patent review.Solid Lipid Nanoparticles: A Potential Multifunctional Approach towards Rheumatoid Arthritis Theranostics.Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis.Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties.Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.How can lipid nanocarriers improve transdermal delivery of olanzapine?SPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agent
P2860
Q23920953-015D80B2-A63B-4E1C-93DF-2AD44C3996D2Q26775886-3AE043D8-75CF-432C-B673-ECFB0126B081Q26859021-93BF1385-B2FA-46A5-8BC3-489E9B80F212Q30366990-BFACF1E8-3BD2-4126-A3D8-D8FFA3634922Q33683206-628E8BB3-08AE-4EA2-827D-EDC7A9011C72Q33734460-3C71B622-809C-40F6-8D46-CC2934AE9E6EQ35883589-D92827F4-61C2-4361-90ED-EB0E80ED58E4Q35981175-EA94A92F-F444-4CDB-A0D6-6982B6E4512DQ36978587-5776A1BC-B34F-4CC3-9B31-887D2AC5A710Q37239461-B08AA8AE-107B-494A-9927-E71AF67F31CFQ37341571-BDAB6440-8BE7-4113-8F2A-E7E1A5224305Q37474497-50375D4A-C86A-40C4-A170-1CCCC521EE95Q37646827-6EF15E39-988E-4054-98C9-E3A90B3B1790Q37722890-583581EF-1990-4F5D-BC51-5590F271C464Q38196446-B4E3AAED-4B0F-48BE-A4A2-F57FB7A8A79CQ38199540-C996E15F-CC59-4CEE-97EC-080E90C0F37AQ38324016-DE71AE70-A693-4821-ACCC-2D1F1B90D752Q38424828-4EA2A741-FA71-4292-AF20-71D8C3A20A84Q38522125-A2883E2F-6E66-473B-A771-28B7110A980BQ38597794-F7784D8B-519C-4405-87D5-2C710123C4E1Q38664367-7EA8241C-9E7F-4EEA-BB95-E154F2ED62B7Q38862535-01D75604-ABC1-4910-B208-D30E5735133FQ38863577-F3397C60-B008-4C12-BF06-76B10EBDB64AQ39574444-7E279E01-3CF9-4768-A75D-BFECA289E822Q40104332-0E70BE59-4E6A-44C0-AF4A-AFFC2CED4870Q47447720-7327398A-FA7D-4729-BAF1-BBD49E74256BQ48225327-87701171-7D6B-426D-B481-C9C3716D5F83Q49370039-566B7CFD-AF4D-4814-9249-F558DCE471C9Q53551032-C60029EC-43B0-4D31-BD24-7E32472273A4Q53667150-AF024369-73B6-42F8-8E74-2C67A8CE8D5DQ57300757-D61EDB8E-0AEA-40CA-8C33-9EC5C078499C
P2860
Nanostructured lipid carriers system: recent advances in drug delivery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nanostructured lipid carriers system: recent advances in drug delivery.
@en
type
label
Nanostructured lipid carriers system: recent advances in drug delivery.
@en
prefLabel
Nanostructured lipid carriers system: recent advances in drug delivery.
@en
P2093
P2860
P50
P1476
Nanostructured lipid carriers system: recent advances in drug delivery
@en
P2093
Jasjeet Kaur Sahni
Md Asif Iqbal
Shweta Dang
P2860
P304
P356
10.3109/1061186X.2012.716845
P577
2012-08-29T00:00:00Z